Sleep Apnea, Central: Clinical Trials

4 trials for Sleep Apnea, Central, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated, 1 completed. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Terminated 3, Completed 1
Phase 21Completed 1

Follow Sleep Apnea, Central: new trials by email Literature Review of Sleep Apnea, Central trials Research Report on Sleep Apnea, Central

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Impact of Low Flow Nocturnal Oxygen Therapy on Hospital Admissions and Mortality in Patients With Heart Failure and Central Sleep Apnea
Oxygen, Room Air - Heart Failure, Central Sleep Apnea
Phase 3TerminatedBrigham and Women's Hospital982019-04-152023-08-01
Morphine in Moderate Obstructive Sleep Apnoea
Morphine sulphate - Obstructive Sleep Apnoea
Phase 3TerminatedPapworth Hospital NHS Foundation Trust62016-05-202018-11-29
Assessment of Desogestrel in Ondine Syndrome
desogestrel - Ondine Syndrome
Phase 2 / Phase 3CompletedAssistance Publique - Hôpitaux de Paris62011-04-012013-11-14
Buspirone as a Potential Treatment for Recurrent Central Apnea
Acetazolamide, Buspirone - Central Apnea, Heart Failure
Phase 3TerminatedVA Office of Research and Development82008-09-012016-03-14

Narrower conditions

Heart Failure (2)  ·  Agnosia (1)  ·  Cheyne-Stokes Respiration (1)  ·  Hypercapnia (1)  ·  Hypoxia (1)  ·  Respiratory Aspiration (1)  ·  Sleep Apnea Syndromes (1)  ·  Sleep Apnea, Obstructive (1)

Broader conditions

Apnea (4)  ·  Dyssomnias (4)  ·  Nervous System Diseases (4)  ·  Respiration Disorders (4)  ·  Respiratory Tract Diseases (4)  ·  Sleep Disorders, Intrinsic (4)  ·  Sleep Wake Disorders (4)  ·  Sleep Apnea Syndromes (3)  ·  Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Perceptual Disorders (1)

Interventions

Acetazolamide (1)  ·  Buspirone (1)  ·  Desogestrel (1)  ·  Morphine (1)  ·  Oxygen (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Brigham and Women's Hospital (1)  ·  Papworth Hospital NHS Foundation Trust (1)  ·  VA Office of Research and Development (1)

Countries

United States (2)  ·  France (1)  ·  United Kingdom (1)

Top investigators

Ian Smith, MBBS (1)  ·  Kingman P. Strohl, MD (1)  ·  Martina Mason, MBBS (1)

Results publications

PMID 21801857, PMID 25268234, PMID 38336689, PMID 40929650

NIH funding

U24HL140412 (1)